VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Saturday, January 10, 2026
Stock Comparison
Elevance Health, Inc. vs Symrise AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Elevance Health, Inc.
ELV · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Elevance Health, Inc.'s moat claims, evidence, and risks.
View ELV analysisSymrise AG
SY1 · Xetra
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Elevance Health, Inc. leads (74 / 100 vs 69 / 100 for Symrise AG).
- Segment focus: Elevance Health, Inc. has 3 segments (85.2% in Health Benefits); Symrise AG has 2 segments (61.8% in Taste, Nutrition & Health).
- Moat breadth: Elevance Health, Inc. has 8 moat types across 3 domains; Symrise AG has 5 across 3.
Primary market context
Elevance Health, Inc.
Health Benefits
U.S. health insurance and managed care
United States
Employers, individuals, and government programs
Payer / managed care organization
85.2%
Symrise AG
Taste, Nutrition & Health
Food & beverage flavor ingredients and pet food ingredients
Global
B2B (food & beverage, pet food, aquafeed manufacturers)
Ingredient/formulation supplier
61.8%
Side-by-side metrics
Moat coverage
Shared moat types
Elevance Health, Inc. strengths
Symrise AG strengths
Segment mix
Elevance Health, Inc. segments
Full profile >Health Benefits
Oligopoly
CarelonRx
Oligopoly
Carelon Services
Competitive
Symrise AG segments
Full profile >Taste, Nutrition & Health
Oligopoly
Scent & Care
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.